February 10, 2023 12:10 PM ESTUpdated February 13, 09:18 AM
Pharma
FDA+

Japan can­cels 140M dose or­der for No­vavax Covid vac­cine amid 'low­er than ex­pect­ed' de­mand

Katherine Lewin

News Reporter

Japan has can­celed an or­der for more than 140 mil­lion dos­es of No­vavax’s Covid-19 vac­cine, Take­da re­vealed in an SEC fil­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

Roivant says long-shot drug for a rare lung dis­ease failed its Phase 2 study

Re­lay li­cens­es can­cer drug to Ko­re­an biotech for $75M

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

A service from the Financial Times